Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm (GAS2PLUS)
Evaluation of the Technique of Axillary Sentinel Lymph Node (SLN) Detection in Breast Cancers > 2 cm
Sponsor: Centre Leon Berard
Listed as NCT00636467, this PHASE2 trial focuses on Breast Cancer and remains completed. Sponsored by Centre Leon Berard, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Mar 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Leon Berard
- PHRC 2007: financial support
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Angers, France , Bordeaux, France , Boulogne-sur-Mer, France , Calais, France , Coquelles, France , Cucq, France , Guilherand-Granges, France , Lille, France , Lyon, France , Marseille, France and 11 more locations